RobertP.BaughmanMD

Critical Care Medicine, Pleural Disease

Professor, Internal Medicine, University of Cincinnati College of Medicine

Dr. Baughman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
222 Piedmont Avenue
Suite 4000
Cincinnati, OH 45219
Phone+1 513-475-8523

University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1982 - 1983
University of Cincinnati Medical Center/College of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1980 - 1982
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1977 - 1980
Case Western Reserve University School of MedicineClass of 1977

PubMed

Consensus Recommendations for the Management of Neurosarcoidosis: A Delphi Survey of Experts Across the United States.
Giovanna Sophia Manzano, James Eaton, Michael Levy, Justin R Abbatemarco, Allen J Aksamit
Neurology. Clinical Practice. 2025-04-01
Therapeutic doses of efzofitimod demonstrate efficacy in pulmonary sarcoidosis.
Ogugua Ndili Obi, Robert P Baughman, Elliott D Crouser, Mark W Julian, Landon W Locke
ERJ Open Research. 2025-01-01
3 citations
Developmental drugs for sarcoidosis.
Ogugua Ndili Obi, Lesley Ann Saketkoo, Lisa A Maier, Robert P Baughman
Journal of Autoimmunity. 2024-12-01

aTyr Pharma Announces First Major Review Article for Efzofitimod Published in the Journal Sarcoidosis, Vasculitis and Diffuse Lung DiseasesMarch 30th, 2023
Bellerophon Provides Clinical Program Update and Reports Second Quarter 2022 Financial ResultsAugust 15th, 2022